Subscription Notification
We have noticed that there is an issue with your subscription billing details. Please update your billing details here
Please update your billing information
The subscription details associated with this account need to be updated. Please update your billing details here to continue enjoying your subscription.
Your subscription will end shortly
Please update your billing details here to continue enjoying your access to the most informative and considered journalism in the UK.
Midwestern University partners with Hope s Front Door for wellness workshops
Updated 5/1/2021 1:06 AM
Midwestern University has partnered with the community organization Hope s Front Door to provide a series of health and wellness workshops. The program is designed to help Hope s Front Door clients gain a greater understanding of current healthcare topics and provide strategies to help improve their overall health and wellness. Faculty experts and students from Midwestern University s Multispecialty Clinic provide virtual information sessions on topics such as maintaining good emotional health, chronic illness and stress management, pediatric dental care, staying active during the pandemic, facts and misconceptions about the COVID-19 vaccine, and more. The information sessions will continue throughout the year.
Intellia Therapeutics, Inc. (NASDAQ: NTLA) (before the market open)
Intercept Pharmaceuticals, Inc. (NASDAQ: ICPT) (before the market open)
Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) (before the market open)
Insmed Incorporated (NASDAQ: INSM) (before the market open)
Fulcrum Therapeutics, Inc. (NASDAQ: FULC) (before the market open)
Endo International plc (NASDAQ: ENDP) (before the market open)
Bio-Techne Corporation (NASDAQ: TECH) (before the market open)
Harvard Bioscience, Inc. (NASDAQ: HBIO) (before the market open)
Athenex, Inc. (NASDAQ: ATNX) (before the market open)
Zoetis Inc. (NYSE: ZTS) (before the market open)
Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) (before the market open)
Syros Pharmaceuticals, Inc. (NASDAQ: SYRS) (before the market open)
Sexual assault: How to support survivors - The Washington Post washingtonpost.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from washingtonpost.com Daily Mail and Mail on Sunday newspapers.
Share this article
Share this article
ResearchAndMarkets.com s offering.
The compounding pharmacies market was valued at US$ 9,442.8 million in 2020 and is projected to reach US$ 14,995.1 million by 2028; it is expected to grow at a CAGR of 6.1% from 2021 to 2028.
Drug shortage crisis across the world, benefits associated with compounded medications, and increasing adoption of customized medicine (Personalized medicine) are among the major factors fueling the market growth. Moreover, growing demand for compounding pharmacy during COVID-19 are expected to foster the market growth during the forecast period. However, product recalls and stringent regulatory requirements hinder the growth of the compounding pharmacies market.